My Trials
Manage your clinical trial portfolio and track patient enrollment.
Cardiovascular Prevention Study
active
Trial ID
CT-2024-001
Sponsor
Pfizer
Phase
Phase III
Therapeutic Area
Cardiovascular
Start Date
2024-01-01
End Date
2024-12-31
Revenue
$18,500
Next Visit
2024-01-15
Enrollment Progress15/20
Retention Rate100%
Diabetes Management Trial
recruiting
Trial ID
CT-2024-002
Sponsor
Takeda
Phase
Phase II
Therapeutic Area
Endocrinology
Start Date
2024-02-15
End Date
2025-02-14
Revenue
$12,000
Next Visit
2024-01-18
Enrollment Progress8/12
Retention Rate87.5%
Hypertension Treatment Study
active
Trial ID
CT-2024-003
Sponsor
Novartis
Phase
Phase III
Therapeutic Area
Cardiovascular
Start Date
2023-09-01
End Date
2024-08-31
Revenue
$22,800
Next Visit
2024-01-20
Enrollment Progress12/15
Retention Rate91.7%
Oncology Immunotherapy Study
completed
Trial ID
CT-2023-004
Sponsor
Bristol Myers Squibb
Phase
Phase I
Therapeutic Area
Oncology
Start Date
2023-03-01
End Date
2023-12-31
Revenue
$45,000
Next Visit
N/A
Enrollment Progress6/6
Retention Rate100%
4
Total Trials
41
Total Patients
$98,300
Total Revenue
94.6%
Avg. Retention